Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes

American Heart Journal

Volumn 155, Issue 2, 2008, Pages 369-374

  Rao, Sunil V ^a   Kaul, Padma R ^b   Liao, Lawrence ^a   Armstrong, Paul W ^b   Ohman, E Magnus ^a   Granger, Christopher B ^a   Califf, Robert M ^a,c   Harrington, Robert A ^a   Eisenstein, Eric L ^a   Mark, Daniel B ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLOOD TRANSFUSION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE COSTS; HEMATOLOGIC AGENTS; HEMORRHAGE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS;

EID: 38349018499     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.014     Document Type: Article

References (22)

1. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
2. Moscucci M., Ricciardi M., Eagle K.A., et al. Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions. Am J Cardiol 81 (1998) 702-707
3. Moscucci M., Fox K.A., Cannon C.P., et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
4. Rao S.V., Jollis J.G., Harrington R.A., et al. The relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
5. Rao S.V., O'Grady K., Pieper K.S., et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96 (2005) 1200-1206
6. Eikelboom J.W., Mehta S.R., Anand S.S., et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 (2006) 774-782
7. The OASIS 5 Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354 (2006) 1464-1476
8. Mahoney E.M., Jurkovitz C.T., Chu H., et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 288 (2002) 1851-1858
9. Lincoff A.M., Mark D.B., Tcheng J.E., et al. Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Circulation 102 (2000) 2923-2929
10. Mark D.B., Talley J.D., Topol E.J., et al. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 94 (1996) 629-635
11. Stone G.W., McLaurin B.T., Cox D.A., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 (2006) 2203-2216
12. The GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335 (1996) 775-782
13. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
14. Graves EJ, Kozak LJ. Detailed diagnosis and procedures, National Hospital Discharge Survey 1996. In: DHHS, ed. Vol 98-1799: National Center for Health Statistics; 1998.
15. Yang X., Alexander K.P., Chen A.Y., et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1490-1495
16. Weintraub W.S., Mahoney E.M., Lamy A., et al. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol 45 (2005) 838-845
17. Kugelmass A.D., Cohen D.J., Brown P.P., et al. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol 97 (2006) 322-327
18. Cohen D.J., Lincoff A.M., Lavelle T.A., et al. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am Coll Cardiol 44 (2004) 1792-1800
19. Lincoff A.M., Bittl J.A., Harrington R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
20. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106 (2002) 1893-1900
21. Alexander K.P., Chen A.Y., Newby L.K., et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 114 (2006) 1380-1387
22. Lee P.Y., Alexander K.P., Hammill B.G., et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286 (2001) 708-713